000			02117nam a22005535i 4500
001			978-3-642-21631-2
003			DE-He213
005			20140220083805.0
007			cr nn 008mamaa
008			110830s2011 gw | s |||| 0|eng d
020			_a9783642216312 _9978-3-642-21631-2
024	7		_a10.1007/978-3-642-21631-2 _2doi
050		4	_aRM1-950
072		7	_aMMG _2bicssc
072		7	_aMED071000 _2bisacsh
082	0	4	_a615 _223
100	1		_aYao, Tso-Pang. _eeditor.
245	1	0	_aHistone Deacetylases: the Biology and Clinical Implication _h[electronic resource] / _cedited by Tso-Pang Yao, Edward Seto.
250			_aFirst.
264		1	_aBerlin, Heidelberg : _bSpringer Berlin Heidelberg, _c2011.
300			_aXII, 260 p. _bonline resource.
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
347			_atext file _bPDF _2rda
490	1		_aHandbook of Experimental Pharmacology, _x0171-2004 ; _v206
520			_aThe book highlights work from many different labs that taught us abnormal HDACs potentially contribute to the development or progression of many human diseases including immune dysfunctions, heart disease, cancer, memory impairment, aging, and metabolic disorders.
650		0	_aMedicine.
650		0	_aMedical genetics.
650		0	_aMedical laboratories.
650		0	_aToxicology.
650		0	_aBiochemistry.
650		0	_aPost-translational modification of proteins.
650	1	4	_aBiomedicine.
650	2	4	_aPharmacology/Toxicology.
650	2	4	_aBiomedicine general.
650	2	4	_aPosttranslational Modification.
650	2	4	_aProtein Science.
650	2	4	_aLaboratory Medicine.
650	2	4	_aGene Function.
700	1		_aSeto, Edward. _eeditor.
710	2		_aSpringerLink (Online service)
773	0		_tSpringer eBooks
776	0	8	_iPrinted edition: _z9783642216305
830		0	_aHandbook of Experimental Pharmacology, _x0171-2004 ; _v206
856	4	0	_uhttp://dx.doi.org/10.1007/978-3-642-21631-2
912			_aZDB-2-SBL
999			_c108030 _d108030